Speech by Federal Chancellor Dr. Angela Merkel at the opening of MEDICA 2010 on November 17, 2010, in Düsseldorf:

Germany Angela Merkel · Former Chancellor of Germany

18 November 2010 · Opening of MEDICA 2010 · Düsseldorf, Germany

Context
Merkel addressed attendees at the opening of MEDICA 2010 in Düsseldorf on November 17, 2010, highlighting Germany's health economy and recent healthcare reform.
Main themes
Health economy, medical technology exports, healthcare reform, demographic change, innovation and competitiveness, solidarity-based financing, small and medium-sized enterprises, research funding, telemedicine, German reunification
Duration
~14 min
50th percentile
Words
1,712
50th percentile
Sentences
86
56th percentile
Readability
44
45th percentile
Grade
12.0
46th percentile
Syntax
2.96
42nd percentile
Vocabulary
2.06
20th percentile

Translated from German

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Economic 39%38%
  • Social 33%33%
  • Technological 12%12%
  • Ceremonial 12%12%
  • Institutional 5%5%
  • Geopolitical 0%0%
  • Environmental 0%0%
  • Not in focus 1%

86 sentences in 26 paragraphs

Dear Mr. Franke,

dear Mr. Dornscheidt,

ladies and gentlemen,

above all, dear colleague Philipp Rösler,

I am very pleased to be here in Düsseldorf today. I would like to extend my warmest greetings to the mayor and the lord mayor.

Here, we truly present a unique variety from the pavement to the pacemaker, from the nursing bed to a fully equipped operating room. The range of medical products – our imagination is sufficient, even if we are not experts – is very broad and is comprehensively showcased here at MEDICA. It is an impressive display of what we call the health economy.

The Federal Minister of Health convened a major congress in the spring of this year to focus precisely on this economic sector. Because you are right, Mr. Franke: Sometimes it is the case that everyone thinks of cars, of mechanical engineering, and so on, but that we also have a leading position in the health economy is not yet known everywhere. Therefore, it is important for this industry to be placed in the spotlight. That is also the reason why I am very happy to be here today.

The growth rates are favorable. Given the demographic change in our society, we can hope that the domestic market in the health economy will not collapse, but rather that we need to think about how we can finance healthcare in solidarity, that is, earn money elsewhere. We can certainly achieve this in a special way through the export share in this sector.

Technological progress has its price. There is no question about that. But the cost-effectiveness of the healthcare system is partly better represented by modern methods, as they allow for greater transparency to be achieved more easily. However, not everyone is always happy when there is immediately more transparency in such an industry. Since the healthcare system itself is not free, I always tell all politicians: It is worth understanding as much of it as possible in order to be able to talk a little about transparency, competition, and efficiency with those who work there.

Last Friday, we passed a healthcare reform in the German Bundestag. This will not have gone unnoticed by you. This healthcare reform is characterized by placing the healthcare system on a reasonable financial basis in the long term, by providing something that, in my firm conviction, brings more, not less solidarity. There is indeed a stronger decoupling from labor costs, because we believe that a solidarity-based healthcare system has too high a cost dynamic to be borne in wage-related costs, that is, in costs on the labor market. This naturally means that if one does not want to overburden the individual, the entirety of taxpayers must step in to ensure solidarity. This is also simply more solidary than if the burden is always placed only on those who are subject to social insurance contributions up to the contribution assessment ceiling.

Now, I do not want to bore you further with this, as you are the ones who have beautiful devices and hope that they will be purchased. You do not deal daily with how the money for this is collected. That is the beauty of the healthcare sector. Medical technology made in Germany stands for innovation, precision, and reliability. German companies have an export rate of 65 percent. We hold the second position in the world market after the USA and ahead of Japan. The OECD tells us that global sales of products and services in the health economy will increase to seven trillion US dollars by 2015. This is more than a doubling compared to the year 2000. You can feel the global dynamics in this industry.

It has already been pointed out: Countries like China, but also the Gulf region are increasingly focusing on equipping themselves with outstanding medical technology. Therefore, this is an area where our foreign trade activities can be better bundled and brought to fruition for the benefit of our exports.

In addition, it is, similar to environmental policy, an interesting area where politics and business can work very closely together, also regarding the legal framework. Because the countries that strive to introduce a solidarity-based healthcare system naturally also need our legislative experience, with which we can then create the conditions for products to be sold.

Innovative capability is the essential foundation for competitiveness. Therefore, it is good that we have close cooperation between small and medium-sized enterprises, large companies, universities, and non-university research institutions. The high-tech strategy that we have introduced for certain scientific and research areas, along with the increased focus on research funding in small and medium-sized enterprises, has been a good step that also benefits medical technology. There are many areas where we can look at innovations, whether in emergency medicine or telemedicine.

There is an interesting development – one can say this in the 20th year of German unity: In the last 20 years, the average life years between East and West have equalized. At the time of German reunification, there was a difference of about six years. East Germans lived, on average, six years shorter. If one investigates what this was actually due to, one knows that environmental and nutritional factors certainly played a role. But the real progress has been achieved through a better rescue system, that is, the faster accessibility of a hospital, emergency doctors, and the entire system that belongs to it. Likewise, the better treatment of heart attacks and strokes plays a role. These are the main reasons for the equalization of life expectancy. Here, one sees how important the area of emergency medicine is.

We also want to continue to be helpful with our research program. The MEDICO project of the THESEUS research program is an example of this. It has already been mentioned that we will discuss at the IT Summit on December 7 in Dresden how we can utilize new possibilities of information and communication technology. You see that we are clearly focused on research and innovation in the medical technology industry. The expenditures for research and development as a percentage of sales contribute around nine percent here, which is twice as high as the German industrial average. This means that this is an excellent area for us, because it is clear: Germany will only be able to dominate the markets if we are truly at the forefront in innovative areas. Therefore, it is worthwhile for the federal government and the economy to work closely together here.

The Christian-Liberal coalition has deliberately and despite all consolidation efforts in the budgets emphasized that the area of education and, above all, the area of research can show increases every year and that all research institutions funded by the federal government have clear perspectives for growth over the years. Three billion euros more per year for this area is already a significant commitment given the other developments in public budgets.

As part of the high-tech strategy, the federal cabinet will soon adopt the new framework program for health research. Special attention will be given to personalized medicine, strengthening prevention, ensuring patient care, and further combating common diseases, which are indeed increasing rather than decreasing. This shows that we are truly pooling our forces with the health research program.

Currently, the "German Centers for Health Research" are being established, which express this bundling. Common diseases such as diabetes, neurodegenerative diseases, infections, cardiovascular diseases, cancer, and lung diseases are in particular focus here. These centers are about long-term, equal partnerships between non-university research institutions and university hospitals. This can and should serve as a bridge for a quick exchange between research on one side and implementation in clinical practice on the other side.

A rapid implementation of research results into practice, into new products and services – this is also the purpose of the top cluster competition of the Federal Ministry of Education and Research. Of course, medical fields are also among the winners – alongside a biotech cluster, there is also a medical technology cluster, which is of particular importance for the tasks we are discussing here today.

I have already mentioned that it is also important to promote small and medium-sized enterprises and to bring them closer to research. You mentioned that many exhibitors here are small and medium-sized enterprises. SMEs have the opportunity to respond quickly to global changes. Therefore, I am pleased that during my tour, I can not only look at the large companies but also at companies from the medium-sized sector.

Openness to new technologies is an essential prerequisite for us to remain successful in the future. This is certainly a topic that will continue to occupy us. We advocate for medical, engineering, mathematical, and natural science professions.

The health economy is thus a dynamic sector that affects all people and interests many, whether it is the heart patient in a rural area who can be cared for by his family doctor using telemedicine methods, or the arthritis patient who can walk again with a new hip prosthesis, or children who are suffering from cancer and who have a chance for a good life in health with better diagnosis and earlier treatment options. This means that, despite all the technology, it is always about people who have expectations and hopes. It is also an industry where you can say every evening when you go home after doing your work: We have made people happy again.

I believe that in this sense, research and development in this area is progressing particularly well. Because the faster new products come to market, the more lives can be saved or the more people can live healthily. Therefore, I think you are all excited to be working in this industry, and that is why you are also proud of this MEDICA, where medical technology is presented in its complexity.

I wish you understanding customers who immediately see where the innovations are and who are immediately convinced that the added value of the products is necessary, and therefore make a new purchase. At the same time, as the head of government, I must also tell you: Be frugal with the funds largely provided by the citizens and make the best of it.

I look forward to being able to see some things now.